In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Poster Session 6: Thrombosis and antithrombotic therapy
Session

Event : ESC Congress 2013

Topic : Other

  • Session type : Poster Session
  • Date : 03 September 2013
  • Time : 08:30 - 12:30

75 presentations in this session

Discussant: thrombosis and antithrombotic therapy.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy

Reduction in recurrent ischemic events with vorapaxar: results from TRACER

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : H White (Auckland,NZ)

Perioperative management of oral antiplatelet therapy in patients with coronary stents undergoing surgery

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : R Rossini (Cuneo,IT)

High on-treatment platelet reactivity, a marker of bleeding risk? an analysis of the ARCTIC study

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : JP Collet (Paris,FR)

Rapid onset and offset of action of otamixaban, a potent direct intravenous factor Xa inhibitor.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : P Grosjean (Chilly-Mazarin,FR)

Clopidogrel resistance in patients with ST-elevation myocardial infarction is associated with high body mass index

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : I Seljeflot (Oslo,NO)

Reversal of anticoagulant effects of apixaban with non-specific prohaemostatic agents: an in vitro study

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : A Martin (Paris,FR)

Dose of aspirin does not inluence laboratory antiplatelet efficacy of P2Y12 inhibitors

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : Z Motovska (Prague,CZ)

Switching of P2Y12 inhibitor in patients with acute coronary syndrome: Insights from the GReek AntiPlatElet Registry (GRAPE)

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : I Xanthopoulou (Limassol,CY)

Patterns of antiplatelet therapy in patients who have experienced an acute coronary event: a descriptive study in primary care.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : LA Garcia Rodriguez (Madrid,ES)

Pretreatment with prasugrel is safe and associated with an improvement outcome in patients with NSTE-ACS

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : U Zeymer (Ludwigshafen,DE)

Ticagrelor is frequently discontinued in a real world setting

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : T Bergmeijer (Nieuwegein,NL)

Dabigatran and rivaroxaban do not influence TRAP, ADP and AA induced platelet aggregation in cardiac patients

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : C Olivier (Freiburg,DE)

Restoration of platelet function with platelet transfusion in cardiac surgery patients on dual antiplatelet therapy.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : S O'Connor (Waterford,IE)

Rapamycin modulates anti- and pro-thrombotic gene expressions via Kruppel-like factor 2: in vitro studies

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : JJ Li (Beijing,CN)

Modulation of complement C3 levels and fibrin clot structure: the role of aspirin dose.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : K Schutt (Aachen,DE)

Correlation of clinical findings and clot ultrastructure in coronary and peripheral arterial thrombi

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : AI Nagy (Budapest,HU)

High rate of ticagrelor and prasugrel- non-responder in patients in therapeutic hypothermia after cardiac arrest

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : K Ibrahim (Dresden,DE)

Stent thrombosis after primary angioplasty - incidence, timing and long term prognostic: 5 year follow-up registry

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : A Monteiro (Lisbon,PT)

High neutrophils and low CD34+ cell count are associated with increased risk of venous thromboembolism

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : M Rattazzi (Padova,IT)

TAILOR- Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : NP Dridi (Copenhagen O,DK)

Ticagrelor or prasugrel in STEMI patients: a pharmacodynamic evaluation

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : M Kerneis (Paris,FR)

Identification of a new biomarker for in vivo evaluation of blood coagulation and platelet activation

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : C Beauloye (Brussels,BE)

Acute effects of clopidogrel are predicted by integrity of prostacyclin signalling.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : VB Nooney (Adelaide,AU)

Enhanced platelet reactivity in pediatric depression: an observational study.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : MM Can (Istanbul,TR)

Long-term outcomes in patients with early, late and very late stent thrombosis after bare metal stenting

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : J Shimotakahara (Kagoshima,JP)

Onset of antiplatelet effect of prasugrel and ticagrelor is delayed in patients with acute coronary syndromes

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : D Trenk (Bad Krozingen,DE)

An unexpected risk predictor in acute coronary syndromes.

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : PF Monteiro (Coimbra,PT)

Mean platelet volume during the course of STEMI and primary PCI

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : G Matic (Beograd,RS)

Platelet aggregation and fibrin clot structure in patients with coronary artery disease and previous myocardial infarction

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : S Neergaard-Petersen (Aarhus N,DK)

Impact of ranitidine on platelet aggregation in patients taking clopidogrel

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : R Furtado (Sao Paulo,BR)

Influence of CYP2C19 *2 and *3 loss-of-function alleles on phenotyping and clopidogrel pharmacodynamics

Event : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : YH Jeong (Changwon,KR)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are